EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

N E W S    R E L E A S E  

LOGO

 

Contact:   

Karey L. Witty

  

Chief Financial Officer

  

(314) 725-4477

  

Lisa M. Wilson

  

Senior Vice President, Investor Relations

  

(212) 759-3929

CENTENE CORPORATION REPORTS FIRST QUARTER 2006 EARNINGS RESULTS

ST. LOUIS, MISSOURI (April 25, 2006) — Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended March 31, 2006.

First Quarter Highlights

 

  Revenues of $455.1 million, a 37% increase.

 

  A 70 basis point increase in sequential quarter health benefits ratio (HBR) in the Medicaid and SCHIP category, primarily due to pharmacy costs in Indiana.

 

  Earnings from operations of $12.6 million.

 

  Earnings per diluted share of $0.20.

 

  Membership growth of 12.5%.

 

  Operating cash flows of $9.3 million.

 

  Days in claims payable of 43.0.

 

  Closed acquisition of US Script, a pharmacy benefit manager based in Fresno, California.

 

  Signed definitive agreement to acquire MediPlan Corporation through Ohio subsidiary.

 

  Received preliminary notification of Ohio Medicaid contract awards, increasing counties served to 27.

Michael F. Neidorff, Centene’s chairman and chief executive officer, said: “The first quarter of 2006 met our expectations, although our results were affected by some market specific factors. In particular, higher pharmacy costs in Indiana, and to a limited degree in Ohio, impacted our overall medical costs, adding 70 basis points to our Medicaid and SCHIP HBR. We have been actively working to address these issues and are confident that the pharmacy costs will normalize in the short-term. Importantly, our purchase of US Script has provided us with an important


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 2

vehicle to mitigate and positively influence our pharmacy costs. Indiana and Ohio will be transitioned to US Script in May. Wisconsin was converted to the US Script platform in March, and we are already seeing the benefit of this implementation.

“We are pleased with our progress in Kansas and New Jersey, and the new membership opportunities in Ohio and Georgia. We recently received notification from the State of Ohio of our preliminary acceptance to serve Medicaid recipients in the Northwest and East Central regions, our existing service areas. Together with the MediPlan acquisition, we are solidly positioned in the State.

“On February 15, 2006, the Georgia Department of Community Health issued a 60-day delay in implementing its new managed care initiative to June 1, 2006. Nevertheless, our subsidiary Peach State Health Plan is, and will remain, ready to partner with the State’s Medicaid and PeachCare for Kids programs. We have successfully completed all readiness reviews and are poised for significant growth in this start-up market.

“We look forward to the Georgia and Ohio implementations, and additional opportunities for growth,” concluded Neidorff.

Membership totaled 874,800 at March 31, 2006, a 12.5% increase from 777,300 at March 31, 2005. The following table depicts Medicaid Managed Care membership by state at March 31, 2006 and 2005:

 

     2006     2005

Indiana

   193,000     149,900

Kansas

   118,200     94,900

Missouri

   34,500     41,300

New Jersey

   57,500     52,700

Ohio

   59,000 *   23,900

Texas

   237,500     243,700

Wisconsin

   175,100     170,900
          

TOTAL

   874,800     777,300
          

* Excludes pending acquisition of MediPlan Corporation

 

2


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 3

The following table depicts Medicaid Managed Care membership by member category at March 31, 2006 and 2005:

 

     2006     2005  

Medicaid

   683,700     588,100  

SCHIP

   175,300     178,500  

SSI

   15,800 (a)   10,700 (b)
            

TOTAL

   874,800     777,300  
            

(a) 8,600 at-risk; 7,200 ASO
(b) 4,500 at-risk; 6,200 ASO

The following table depicts Specialty Services membership by state at March 31, 2006 and 2005:

 

     2006    2005

Arizona

   92,300    —  

Kansas

   39,200    35,400
         

TOTAL

   131,500    35,400
         

(1) Includes behavioral health contracts only.

Statement of Earnings Highlights

 

    For the first quarter of 2006, revenues increased 36.9% to $455.1 million from $332.4 million in the first quarter of 2005. The increase in service revenues for the first quarter of 2006 reflects the acquisitions of both AirLogix and US Script.

 

    The HBR for Centene’s Medicaid and SCHIP populations, which reflects medical costs as a percent of premium revenues, was 82.8% for the first quarter of 2006, compared to 80.6% for the same period in 2005. The results for the first quarter of 2006 reflected: (1) higher utilization trends in certain markets, especially in January 2006; (2) an increase in pharmacy related costs in Centene’s Indiana and Ohio markets; and (3) Centene’s earlier expansion into new unmanaged markets. The HBR

 

3


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 4

for the SSI category was 87.6% for the first quarter of 2006 compared to 94.6% for the first quarter of 2005 and, while approaching Centene’s target range, may be volatile given the small member base. For the Specialty Services segment, the HBR was 84.1% in the first quarter of 2006 versus 133.5% in the first quarter of 2005. The Specialty Services HBR for 2006 included the behavioral health contracts in Arizona and Kansas, while the 2005 results included only the first three months of the behavioral health contract in Kansas.

 

    Medicaid Managed Care general and administrative (G&A) expenses as a percent of revenues was 11.9% in the first quarter of 2006 compared to 10.8% in the first quarter of 2005, mainly reflecting Georgia start-up costs and the expensing of stock-based compensation as the result of Centene’s adoption of SFAS No. 123R. In addition, concurrent with the closing of the US Script acquisition, the Company altered its corporate function allocation methodology to more closely align those allocations to the proportion of costs required to support each business segment. The effect of this change added 0.7% in G&A expenses to the Medicaid Managed Care G&A ratio for the first quarter of 2006.

 

    Earnings from operations of $12.6 million in the first quarter of 2006 compared to $21.3 million in the first quarter of 2005, inclusive of Georgia start-up costs.

 

    Net earnings were $8.8 million, or $0.20 per diluted share, for the first quarter of 2006, compared to $14.4 million, or $0.32 per diluted share, for the first quarter of 2005.

Balance Sheet and Cash Flow Highlights

At March 31, 2006, the Company held cash and investments of $339.8 million, a portion of which was restricted due to state regulatory requirements. Premium and related receivables increased $22.3 million during the first quarter of 2006, primarily reflecting an increase in capitation receivables and reimbursements due from providers, including amounts due under capitated risk-sharing contracts. The increase also reflected customer receivables due to US Script, which was acquired as of January 1, 2006. Medical claims liabilities totaled $172.8 million

 

4


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 5

at March 31, 2006, representing 43.0 days in claims payable. A reconciliation of the Company’s change in days in claims payable from the immediately preceding quarter is highlighted below:

 

Days in claims payable, December 31, 2005

   45.4  

Decrease in claims inventory

   (1.8 )

Conversion of pharmacy benefits to U.S. Script

   (0.6 )
      

Days in claims payable, March 31, 2006

   43.0  
      

The Company had cash flows from operating activities of $9.3 million for the quarter ended March 31, 2006.

Outlook

Karey L. Witty, Centene’s chief financial officer, commented, “For the second quarter of 2006, we expect revenue in the range of $495 million to $500 million and earnings per diluted share of $0.25 to $0.30. For the full-year 2006, we anticipate revenue in the range of $2.08 billion to $2.16 billion and earnings per diluted share of $1.53 to $1.70. This guidance excludes our recently announced acquisition of MediPlan Corporation, which we expect to close during the second quarter of 2006.”

Conference Call

As previously announced, the Company will host a conference call later today, April 25, 2006, at 8:30 AM Eastern Time to review the financial results for the first quarter ended March 31, 2006, and to discuss its business outlook. Michael F. Neidorff and Karey L. Witty will host the conference call. Investors are invited to participate in the conference call by dialing (800) 273-1254 in the United States and Canada, and (706) 679-8592 for international participants, or via a live Internet broadcast at the Company’s website, www.centene.com. A replay of the call will be available from April 25, 2006, shortly after completion of the call, until May 9, 2006, at 11:59 PM Eastern Time. Investors may dial (800) 642-1687 in the United States and (706) 645-9291 from abroad and enter access number 7620184.

 

5


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 6

About Centene Corporation

Centene Corporation is a leading multi-line healthcare enterprise that provides programs and related services to individuals receiving benefits under Medicaid, including Supplemental Security Income (SSI) and the State Children’s Health Insurance Program (SCHIP). The Company operates health plans in Indiana, Kansas, Missouri, New Jersey, Ohio, Texas and Wisconsin. In addition, the Company contracts with other healthcare organizations to provide specialty services including behavioral health, disease management, nurse triage, pharmacy benefit management and treatment compliance. Information regarding Centene is available via the Internet at www.centene.com.

The information provided in the first paragraph following the bullet listing under “First Quarter Highlights” and in the paragraph under “Outlook” above contain forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company’s estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene’s or its industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene’s ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene’s Medicaid managed care contracts by state governments would also negatively affect Centene.

[Tables Follow]

 

6


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 7

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

    

March 31,

2006

   

December 31,

2005

 
     (Unaudited)  
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 118,512     $ 147,358  

Premium and related receivables, net of allowances of $611 and $343, respectively

     66,368       44,108  

Short-term investments, at fair value (amortized cost $71,400 and $56,863, respectively)

     71,172       56,700  

Other current assets

     24,992       24,439  
                

Total current assets

     281,044       272,605  

Long-term investments, at fair value (amortized cost $130,189 and $126,039, respectively)

     127,289       123,661  

Restricted deposits, at fair value (amortized cost $23,081 and $22,821, respectively)

     22,788       22,555  

Property, software and equipment, net

     82,853       67,199  

Goodwill

     196,986       157,278  

Other intangible assets, net

     19,341       17,368  

Other assets

     7,506       7,364  
                

Total assets

   $ 737,807     $ 668,030  
                
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current liabilities:

    

Medical claims liabilities

   $ 172,792     $ 170,514  

Accounts payable and accrued expenses

     47,779       29,790  

Unearned revenue

     12,494       13,648  

Current portion of long-term debt and notes payable

     1,712       699  
                

Total current liabilities

     234,777       214,651  

Long-term debt

     130,940       92,448  

Other liabilities

     7,841       8,883  
                

Total liabilities

     373,558       315,982  

Stockholders’ equity:

    

Common stock, $.001 par value; authorized 100,000,000 shares; issued and outstanding 43,072,053 and 42,988,230 shares, respectively

     43       43  

Additional paid-in capital

     195,669       191,840  

Accumulated other comprehensive income:

    

Unrealized loss on investments, net of tax

     (2,148 )     (1,754 )

Retained earnings

     170,685       161,919  
                

Total stockholders’ equity

     364,249       352,048  
                

Total liabilities and stockholders’ equity

   $ 737,807     $ 668,030  
                

 

7


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 8

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EARNINGS

(In thousands, except share data)

 

    

Three Months Ended

March 31,

 
     2006     2005  
     (Unaudited)  
Revenues:     

Premium

   $ 435,562     $ 330,944  

Service

     19,516       1,432  
                

Total revenues

     455,078       332,376  
                
Expenses:     

Medical costs

     361,672       267,756  

Cost of services

     15,588       843  

General and administrative expenses

     65,222       42,459  
                

Total operating expenses

     442,482       311,058  
                

Earnings from operations

     12,596       21,318  
Other income (expense):     

Investment and other income

     3,540       2,120  

Interest expense

     (1,998 )     (562 )
                

Earnings before income taxes

     14,138       22,876  
Income Tax Expense      5,372       8,465  
                

Net earnings

   $ 8,766     $ 14,411  
                

Earnings per share:

    

Basic earnings per common share

   $ 0.20     $ 0.35  

Diluted earnings per common share

   $ 0.20     $ 0.32  

Weighted average number of shares outstanding:

    

Basic

     42,987,892       41,560,587  

Diluted

     44,750,271       44,861,989  

 

8


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 9

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

    

Three Months Ended

March 31,

 
     2006     2005  
     (Unaudited)  

Cash flows from operating activities:

    

Net earnings

   $ 8,766     $ 14,411  

Adjustments to reconcile net earnings to net cash provided by operating activities —

    

Depreciation and amortization

     4,520       2,782  

Excess tax benefits from stock compensation

     —         2,871  

Stock compensation expense

     3,417       1,091  

Loss (gain) on sale of investments

     12       10  

Loss on disposal of property and equipment

     30       183  

Deferred income taxes

     232       (983 )

Changes in assets and liabilities —

    

Premium and related receivables

     (15,812 )     (5,512 )

Other current assets

     (2,894 )     (4,268 )

Other assets

     (158 )     (491 )

Medical claims liabilities

     2,278       11,602  

Unearned revenue

     (934 )     (21 )

Accounts payable and accrued expenses

     9,937       (2,446 )

Other operating activities

     (51 )     648  
                

Net cash provided by operating activities

     9,343       19,877  
                

Cash flows from investing activities:

    

Purchase of property, software and equipment

     (14,136 )     (3,665 )

Purchase of investments

     (53,194 )     (21,767 )

Sales and maturities of investments

     33,827       27,542  

Acquisitions, net of cash acquired

     (39,912 )     —    
                

Net cash (used in) provided by investing activities

     (73,415 )     2,110  
                

Cash flows from financing activities:

    

Proceeds from exercise of stock options

     2,139       1,390  

Proceeds from borrowings

     37,000       —    

Payment of long-term debt and notes payable

     (2,285 )     (4,121 )

Excess tax benefits from stock compensation

     1,454       —    

Common stock repurchases

     (3,082 )     —    

Other financing activities

     —         (85 )
                

Net cash provided by (used in) financing activities

     35,226       (2,816 )
                

Net (decrease) increase in cash and cash equivalents

     (28,846 )     19,171  
                

Cash and cash equivalents, beginning of period

     147,358       84,105  
                

Cash and cash equivalents, end of period

   $ 118,512     $ 103,276  
                

Interest paid

   $ 2,037     $ 692  

Income taxes paid

   $ 911     $ 1,133  

Supplemental schedule of non-cash financing activities:

    

Property acquired under capital leases

   $ 26     $ —    

 

9


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 10

CENTENE CORPORATION

SUPPLEMENTAL FINANCIAL DATA

 

    

Q1

2006

   

Q4

2005

   

Q3

2005

   

Q2

2005

 

MEMBERSHIP

        

Medicaid Managed Care:

        

Indiana

     193,000       193,300       176,300       152,800  

Kansas

     118,200       113,300       107,600       103,000  

Missouri

     34,500       36,000       37,300       39,900  

New Jersey

     57,500       56,500       50,900       52,900  

Ohio

     59,000       58,700       58,100       59,600  

Texas

     237,500       242,000       243,600       243,800  

Wisconsin

     175,100       172,100       173,900       173,400  
                                

TOTAL

     874,800       871,900       847,700       825,400  
                                

Medicaid

     683,700       681,100       657,500       637,300  

SCHIP

     175,300       175,900       176,900       176,200  

SSI

     15,800       14,900       13,300       11,900  
                                

TOTAL

     874,800       871,900       847,700       825,400  
                                

Specialty Services(a):

        

Arizona

     92,300       94,700       94,300       —    

Kansas

     39,200       38,800       37,500       37,100  
                                

TOTAL

     131,500       133,500       131,800       37,100  
                                
                                 

(a)  Includes behavioral health contracts only.

    

REVENUE PER MEMBER(b)

   $ 157.17     $ 152.48     $ 147.73     $ 143.41  

CLAIMS(b)

        

Period-end inventory

     229,800       255,000       206,900       195,500  

Average inventory

     175,200       153,500       148,300       170,300  

Period-end inventory per member

     0.26       0.29       0.24       0.24  

(b) Revenue per member and claims information are presented for the Medicaid Managed Care segment.

   

DAYS IN CLAIMS PAYABLE (c)

     43.0       45.4       41.4       49.5  

(c)  Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.

     

CASH AND INVESTMENTS (in millions)

        

Regulated

   $ 314.0     $ 322.6     $ 305.1     $ 260.5  

Unregulated

     25.8       27.7       27.7       27.4  
                                

TOTAL

   $ 339.8     $ 350.3     $ 332.8     $ 287.9  
                                

ANNUALIZED RETURN ON EQUITY (d)

     9.8 %     16.2 %     14.9 %     20.0 %

(d) Annualized Return on Equity is calculated as follows: (net income for quarter x 4) divided by ((beginning of period equity + end of period equity) divided by 2).

  

 

10


Centene Corporation Reports First Quarter 2006 Earnings Results April 25, 2006 / Page 11

HEALTH BENEFITS RATIO BY CATEGORY:

 

    

Three Months Ended

March 31,

 
     2006     2005  

Medicaid and SCHIP

   82.8 %   80.6 %

SSI

   87.6     94.6  

Specialty Services

   84.1     133.5  

GENERAL AND ADMINISTRATIVE EXPENSE RATIO BY BUSINESS SEGMENT:

 

    

Three Months Ended

March 31,

 
     2006     2005  

Medicaid Managed Care

   11.9 %   10.8 %

Specialty Services

   22.3     50.2  

MEDICAL CLAIMS LIABILITIES

(In thousands)

Four rolling quarters of the changes in medical claims liabilities are summarized as follows:

 

Balance, March 31, 2005

   $ 177,582  

Acquisitions

     —    

Incurred related to:

  

Current period

     1,332,120  

Prior period

     (11,295 )
        

Total incurred

     1,320,825  
        

Paid related to:

  

Current period

     1,160,178  

Prior period

     165,437  
        

Total paid

     1,325,615  
        

Balance, March 31, 2006

   $ 172,792  
        

Centene’s claims reserving process utilizes a consistent actuarial methodology to estimate Centene’s ultimate liability. Any reduction in the “Incurred related to: Prior period” claims may be offset as Centene actuarially determines “Incurred related to: Current period.” As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs. Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

 

11